Collaborative Endocrine Surgery Quality Improvement Program (CESQIP) Receives CMS Approval as a Qualified Clinical Data Registry

The Collaborative Endocrine Surgery Quality Improvement Program (CESQIP) has been approved by the Centers for Medicare and Medicaid Services (CMS) as a Qualified Clinical Data Registry (QCDR) for the 2017 reporting year. CESQIP participants can now fulfill requirements of the Merit-based Incentive Payment System (MIPS) under the CMS Quality Payment Program (QPP) via the CESQIP QCDR.

“Becoming a QCDR is a logical and strategic progression for CESQIP that expands the utility and value of CESQIP participation,” said William B. Inabnet III, MD, FACS, Chair, Department of Surgery, Mount Sinai Beth Israel, and President of the Endocrine Surgery Quality Foundation, which oversees CESQIP. “CESQIP will continue to aim to improve the value of care delivered to patients by helping endocrine surgeons make informed decisions quickly and facilitate continuous improvement. The QCDR now adds to the power of CESQIP by providing a highly practical and relevant suite of tools that will help ease the burden of quality reporting.”

The CESQIP QCDR captures and analyzes data that are clinically relevant and appropriate for endocrine surgeons. It includes general MIPS measures, as well as six specialty-specific measures developed by CESQIP that are meaningful to endocrine surgeons and their patients. Physicians who participate in the CESQIP QCDR will be able to understand and adjust their 2017 performance to improve patient outcomes and optimize future reimbursements under the CMS QPP.

CESQIP’s technology and analytics partner, ArborMetrix, supported the QCDR self-nomination process. ArborMetrix’s suite of features and reports make it easy for physicians to see how they are performing, identify and implement best practices, improve care, and optimize CMS quality reporting and value-based payment. The CESQIP registry provides real-time reports available on-demand so physicians have easy access to the information that helps them propel performance and improve care, while avoiding penalties and optimizing potential bonus payments from CMS.


The Collaborative Endocrine Surgery Quality Improvement Program (CESQIP) aims to improve the value of care delivered to patients. Formed in 2012 by endocrine surgery leaders from the American Association of Endocrine Surgeons with expertise in outcomes tracking, CESQIP utilizes concepts of continuous quality improvement to improve outcomes and optimize costs. This is accomplished through patient-centered data collection, ongoing performance feedback to clinicians, and improvement based on analysis of collected data and collaborative learning. CESQIP is approved as a QCDR for 2017 reporting under the CMS Merit-based Incentive Payment System.